These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 29254508)

  • 21. Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function.
    Clavijo PE; Friedman J; Robbins Y; Moore EC; Smith E; Zauderer M; Evans EE; Allen CT
    Cancer Immunol Res; 2019 Feb; 7(2):282-291. PubMed ID: 30514791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.
    Gannon PO; Godin-Ethier J; Hassler M; Delvoye N; Aversa M; Poisson AO; Péant B; Alam Fahmy M; Saad F; Lapointe R; Mes-Masson AM
    PLoS One; 2010 Aug; 5(8):e12107. PubMed ID: 20711410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
    Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
    J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.
    Highfill SL; Rodriguez PC; Zhou Q; Goetz CA; Koehn BH; Veenstra R; Taylor PA; Panoskaltsis-Mortari A; Serody JS; Munn DH; Tolar J; Ochoa AC; Blazar BR
    Blood; 2010 Dec; 116(25):5738-47. PubMed ID: 20807889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
    Otvos B; Silver DJ; Mulkearns-Hubert EE; Alvarado AG; Turaga SM; Sorensen MD; Rayman P; Flavahan WA; Hale JS; Stoltz K; Sinyuk M; Wu Q; Jarrar A; Kim SH; Fox PL; Nakano I; Rich JN; Ransohoff RM; Finke J; Kristensen BW; Vogelbaum MA; Lathia JD
    Stem Cells; 2016 Aug; 34(8):2026-39. PubMed ID: 27145382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.
    Weis-Banke SE; Lisle TL; Perez-Penco M; Schina A; Hübbe ML; Siersbæk M; Holmström MO; Jørgensen MA; Marie Svane I; Met Ö; Ødum N; Madsen DH; Donia M; Grøntved L; Andersen MH
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36316062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response.
    Park JA; Wang L; Cheung NV
    J Hematol Oncol; 2021 Sep; 14(1):142. PubMed ID: 34496935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ARG1 functions as a tumor suppressor in breast cancer.
    Ming Z; Zou Z; Cai K; Xu YI; Chen X; Yi W; Luo J; Luo Z
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1257-1264. PubMed ID: 33128544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine-Mediated Regulation of ARG1 in Macrophages and Its Impact on the Control of
    Brigo N; Pfeifhofer-Obermair C; Tymoszuk P; Demetz E; Engl S; Barros-Pinkelnig M; Dichtl S; Fischer C; Valente De Souza L; Petzer V; von Raffay L; Hilbe R; Berger S; Seifert M; Schleicher U; Bogdan C; Weiss G
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia.
    Haydar D; Gonzalez R; Garvy BA; Garneau-Tsodikova S; Thamban Chandrika N; Bocklage TJ; Feola DJ
    Immunobiology; 2021 Jan; 226(1):152034. PubMed ID: 33278710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy.
    Lechner MG; Karimi SS; Barry-Holson K; Angell TE; Murphy KA; Church CH; Ohlfest JR; Hu P; Epstein AL
    J Immunother; 2013; 36(9):477-89. PubMed ID: 24145359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.
    Gao A; Liu X; Lin W; Wang J; Wang S; Si F; Huang L; Zhao Y; Sun Y; Peng G
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer.
    Rotondo R; Barisione G; Mastracci L; Grossi F; Orengo AM; Costa R; Truini M; Fabbi M; Ferrini S; Barbieri O
    Int J Cancer; 2009 Aug; 125(4):887-93. PubMed ID: 19431148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
    Sun L; Clavijo PE; Robbins Y; Patel P; Friedman J; Greene S; Das R; Silvin C; Van Waes C; Horn LA; Schlom J; Palena C; Maeda D; Zebala J; Allen CT
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the arginine metabolic brake enhances immunotherapy for leukaemia.
    Mussai F; Wheat R; Sarrou E; Booth S; Stavrou V; Fultang L; Perry T; Kearns P; Cheng P; Keeshan K; Craddock C; De Santo C
    Int J Cancer; 2019 Oct; 145(8):2201-2208. PubMed ID: 30485425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME).
    Bretz AC; Parnitzke U; Kronthaler K; Dreker T; Bartz R; Hermann F; Ammendola A; Wulff T; Hamm S
    J Immunother Cancer; 2019 Nov; 7(1):294. PubMed ID: 31703604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-arginine metabolism in myeloid cells controls T-lymphocyte functions.
    Bronte V; Serafini P; Mazzoni A; Segal DM; Zanovello P
    Trends Immunol; 2003 Jun; 24(6):302-6. PubMed ID: 12810105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes.
    Vonwirth V; Bülbül Y; Werner A; Echchannaoui H; Windschmitt J; Habermeier A; Ioannidis S; Shin N; Conradi R; Bros M; Tenzer S; Theobald M; Closs EI; Munder M
    Front Immunol; 2020; 11():617699. PubMed ID: 33717053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.